EX-32.1 7 ex_642795.htm EXHIBIT 32.1 ex_642795.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Jennifer K. Simpson, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

 

the Annual Report on Form 10-K of Panbela Therapeutics, Inc for the year ended December 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     

(2)

 

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Panbela Therapeutics, Inc

 

Dated: March 26, 2024

 

 

 

/s/ Jennifer K. Simpson

 

Jennifer K. Simpson

 

President and Chief Executive Officer

 

(Principal Executive Officer)